methylprednisolone has been researched along with plx4032 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ludlow, SP; Pasikhova, Y | 1 |
| Fusumae, T; Inoda, S; Kamiya, K; Kawashima, H; Komine, M; Maekawa, T; Murata, S; Ohtsuki, M; Takahashi, R | 1 |
2 other study(ies) available for methylprednisolone and plx4032
| Article | Year |
|---|---|
Cumulative dermatologic toxicity with ipilimumab and vemurafenib responsive to corticosteroids.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antineoplastic Agents; Disease-Free Survival; Drug Administration Schedule; Exanthema; Female; Humans; Indoles; Ipilimumab; Melanoma; Methylprednisolone; Mutation; Neoplasm Metastasis; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Time Factors; Treatment Outcome; Vemurafenib | 2013 |
Vogt-Koyanagi-Harada disease-like uveitis induced by vemurafenib for metastatic cutaneous malignant melanoma.
Topics: Angiography; Antineoplastic Agents; Female; Humans; Melanoma; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Retina; Skin Neoplasms; Tomography, Optical Coherence; Treatment Outcome; Uveomeningoencephalitic Syndrome; Vemurafenib | 2018 |